quipazine has been researched along with Emesis in 2 studies
Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Litoxetine has moderate affinity for cerebral 5HT3 receptors (Ki = 85 nM), while fluoxetine, similar to other 5HT uptake inhibitors, has only negligible affinity for this receptor (Ki = 6." | 1.29 | Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. ( Angel, I; Garreau, M; Langer, SZ; Prouteau, M; Schoemaker, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angel, I | 1 |
| Schoemaker, H | 1 |
| Prouteau, M | 1 |
| Garreau, M | 1 |
| Langer, SZ | 1 |
| Hayashi, H | 1 |
| Miwa, Y | 1 |
| Ichikawa, S | 1 |
| Yoda, N | 1 |
| Miki, I | 1 |
| Ishii, A | 1 |
| Kono, M | 1 |
| Yasuzawa, T | 1 |
| Suzuki, F | 1 |
2 other studies available for quipazine and Emesis
| Article | Year |
|---|---|
Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties.
Topics: Animals; Antiemetics; Binding, Competitive; Cerebral Cortex; Cisplatin; Dose-Response Relationship, | 1993 |
5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
Topics: Animals; Antiemetics; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; | 1993 |